Pharmafile Logo
Pharmafocus logo
Advanced Search

Oncology

Showing 15 posts of 302 posts found.

Thermosome secures FDA Orphan Drug Designation for soft tissue sarcoma therapy

May 12, 2025
Research and Development European Medicines Agency (EMA), FDA, Oncology, Thermosome

Thermosome has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for its lead candidate, THE001, …

News

Genmab to submit FDA application for lymphoma therapy

May 2, 2025
Research and Development AbbVie, Biologics License Application, FDA, Genmab, Oncology, epcoritamab, lymphoma, therapeutics

Global biotechnology company Genmab plans to submit a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) …

News
researchers_credit_neusentis_pfizer

Ambitious plans for leading cancer research centre announced

May 2, 2025
Market & Product Development, Medical Communications, Research and Development Aviva Capital Partners (ACP), Institute of Cancer Research (ICR), London, London Cancer Hub, Oncology, Royal Marsden NHS Foundation Trust, Socius

Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, have unveiled plans for a …

News

Deadly cancers are being financially left behind, new research claims

May 1, 2025
Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding

New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …

News

Neogap chosen for Innovate Nordics 2025 Acceleration Programme

May 1, 2025
Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …

News

Cervical cancer experts campaign to increase screening rates and save lives

April 30, 2025
Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening

A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …

News

McDavid Stilwell appointed as CFO of CPTx

April 28, 2025
Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics

CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …

Appointment
trialy

Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma

April 25, 2025
Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …

News

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025
Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …

Appointment
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025
Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …

News

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025
Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …

News

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025
Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …

News
blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025
Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …

News

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025
Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …

Appointment

Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer

April 9, 2025
Research and Development Infinitopes, Oncology, biotech, oesophageal cancer, oncology

The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026